PMID: 9169961Jun 1, 1997Paper

Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled study

Journal of Clinical Psychopharmacology
G PernaL Bellodi

Abstract

The effects of short treatments (7 days) with clomipramine and fluvoxamine on the reactivity to inhalations of 35% CO2/65% O2 were compared in 39 panic patients who had positive responses to 35% CO2 inhalations. A double-blind, randomized, placebo-controlled design was applied. Each patient was given the 35% CO2 challenge on days 0 (before starting treatment), 3, and 7. Patients on placebo did not report any significant changes in their reactivity to 35% CO2 across the three sessions, whereas patients on clomipramine and fluvoxamine reported a significant attenuation of the reactivity on day 7. These results indicate that treatments with clomipramine and fluvoxamine decrease hypersensitivity to 35% CO2 after a few days, suggesting a relevant role of the modulation of CO2 sensitivity by the serotonergic system in antipanic properties of these compounds.

References

Dec 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·J Garcia de Yebenes ProusM A Mena Gomez
Dec 1, 1991·Acta Psychiatrica Scandinavica·H PolsE Griez
Jan 1, 1991·Acta Psychiatrica Scandinavica·N ArgyleP Bech
Jun 1, 1990·The American Journal of Psychiatry·E GriezC de Loof
Nov 1, 1990·Biological Psychiatry·J M GormanF Jordan
Jul 1, 1989·Journal of Affective Disorders·T R NormanI M McIntyre
Oct 1, 1989·Psychiatry Research·T R NormanI M McIntyre
Feb 1, 1987·Psychiatry Research·E J GriezG M van der Molen
Aug 1, 1985·Acta Psychiatrica Scandinavica·O Lingjaerde
Jul 1, 1984·The American Journal of Psychiatry·J M GormanD F Klein
May 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·M A Van den Hout, E Griez
Sep 1, 1981·The American Journal of Psychiatry·S GlogerT Troudart
Mar 14, 1995·Journal of Affective Disorders·G PernaM Gasperini
Dec 1, 1994·Acta Psychiatrica Scandinavica·C VerburgJ Meijer
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·H PolsD van der Werf
May 1, 1994·Psychiatry Research·G PernaL Bellodi
Aug 1, 1994·The American Journal of Psychiatry·W C SandersonG M Asnis
Feb 1, 1993·The American Journal of Psychiatry·L A PappJ M Gorman
Oct 1, 1993·Journal of Clinical Psychopharmacology·R Hoehn-SaricP A Hipsley
Jun 1, 1996·The American Journal of Psychiatry·P J HarringtonM J Telch

❮ Previous
Next ❯

Citations

Mar 31, 2004·Psychiatry Research·Giampaolo PernaLaura Bellodi
Dec 22, 1998·Journal of Psychosomatic Research·E Griez, K Schruers
Sep 1, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eduard Maron, Jakov Shlik
Apr 1, 2004·Acta Neuropsychiatrica·K R J SchruersE Griez
Oct 18, 2011·Expert Opinion on Emerging Drugs·Giampaolo PernaDaniela Caldirola
Mar 11, 2006·Journal of Affective Disorders·William CoryellDonald Klein
Oct 22, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Julio Mario Xerfan do AmaralAntonio Egidio Nardi
Aug 12, 2009·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Aline SardinhaAntonio Egidio Nardi
Jul 20, 2002·Arquivos de neuro-psiquiatria·Alexandre M ValençaMárcio Versiani
Aug 19, 2008·Respiratory Physiology & Neurobiology·Antonio E NardiWalter A Zin
Mar 15, 2006·Journal of Psychopharmacology·Jayne E BaileyDavid J Nutt
Sep 8, 2011·Depression and Anxiety·Gabriel EsquivelKoen Schruers
May 15, 2002·Journal of Clinical Psychopharmacology·Giampaolo PernaLaura Bellodi
Jan 25, 2003·Journal of Clinical Psychopharmacology·Angelo BertaniGiampaolo Perna
Jul 29, 2010·Expert Review of Neurotherapeutics·Marina Dyskant Mochcovitch, Antonio Egidio Nardi
Sep 30, 2003·Journal of Psychopharmacology·J E BaileyD J Nutt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.